Skip to main content
Alice Chen, MD, Oncology, Bethesda, MD

AlicePChenMD

Oncology Bethesda, MD

Physician

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chen's full profile

Already have an account?

  • Office

    10 Center Dr
    Bethesda, MD 20892
    Phone+1 301-496-1196

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1991
  • University of Texas Southwestern Medical Center/St Paul Medical Center
    University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1987 - 1989
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1986 - 1987
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1997 - 2026
  • TX State Medical License
    TX State Medical License 1988 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor  
    Kevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology

Authored Content

  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018

Press Mentions

  • Drug Approved to Help Young Patients Battle a Rare Cancer
    Drug Approved to Help Young Patients Battle a Rare CancerJanuary 2nd, 2023
  • Slips, Slides: Winter Injuries Can Be Serious
    Slips, Slides: Winter Injuries Can Be SeriousJanuary 2nd, 2023
  • NIH Clinical Trials Apply Genomics to Chronic Disease Management
    NIH Clinical Trials Apply Genomics to Chronic Disease ManagementJune 6th, 2019
  • Join now to see all

Professional Memberships